Syqe Medical
Syqe is a pharma-tech company developing technologies that enable precise delivery of a wide range of therapeutic molecules by inhalation. Utilizing its breakthrough technology, Syqe aims to relieve the suffering of as many patients as possible in the fastest possible way. The revolutionary Syqe drug delivery technology now allows hundreds of existing and preclinical drug molecules to be considered for inhalation, radically changing their clinical profile and serving significant unmet needs.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Internationally (various countries)
- Year Founded:
- 2011
About Us
Who are we?
Syqe Medical, an innovative MedTech company that developed a breakthrough technology for the administration of medical cannabis by inhalation. We set out on our journey in 2011 with a vision that excited us greatly: to reduce the pain and suffering of as many patients as possible, in the fastest possible way, through advanced technologies and insistent thinking of what our patients really need.
We recognize the beneficial therapeutic effect of medical cannabis and are determined to lead a global change in the standardization of cannabis treatment. We want to transform it into an individually tailored treatment, with a rapid and significant effect, and with minimum adverse events. And at the same time, we want to give physicians the ability to treat patients using cannabis according to the standard of care, while controlling a precise, metered, consistent, and safe dose, which is supported by clinical trials and allows for careful clinical supervision – without exposing the patients to smoking hazards.
What do we do?
We developed the SyqeAir Inhaler – a unique technology that allows physicians and patients to manage cannabis treatment according to the standard of care. A groundbreaking inhaler whose efficacy, safety, and ability to achieve an optimal balance between reduction of pain intensity and control of the psychoactive effects have been demonstrated in clinical trials.
With each inhalation, a consistent and metered amount of THC is released from a raw medical cannabis inflorescence with a full, uniform, and consistent spectrum of the active ingredients. The cannabis is sealed in a designated cartridge, which is loaded securely into the Inhaler, ready for use. The cartridge contains 60 VaporChips (each the size of a sim card), and each VaporChip contains a uniform amount of raw cannabis inflorescence grown in compliance with GMP’s strict production requirements.
The values that guide us
Empathy.
We truly make an effort to listen to our patients and understand their pain and needs.
Integrity.
We are honest, open, ethical, and fair. We do not guarantee what we cannot fulfill.
Innovation.
It is in our nature to innovate and offer the most advanced and accurate solution for our patients.